Pyridines - Administration & dosage
Research News and Information

Saturday, November 21, 2009

Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?

13 Dec 2009 Alveolar rhabdomyosarcoma (RMS) of the extremity is not infrequently associated with regional node metastasis. Knowledge of lymphatic drainage of extremity RMSs is important to determine radiotherapy fields. In this report we describe two patients ... Read more...

Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer.

29 Sep 2009 Metastatic renal cell carcinoma (mRCC) is a highly vascularized tumor with a generally poor prognosis. It is largely resistant to conventional cancer treatment, including most schemes of hormonal and cytokine therapy as well as to modern ... Read more...

[Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel]

29 Sep 2009 To develop a treatment strategy for peritoneal carcinomatosis using a combination of extended peritoneal resections, local destructive procedures and hyperthermic intraperitoneal chemotherapy creates great concern between healthcare workers involved ... Read more...

Latest indexed articles for 'Pyridines - Administration & dosage'

These are the very latest articles for this heading:

• Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? 13 Dec 2009
• Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting. 30 Oct 2009
• Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer. 29 Sep 2009
• [Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel] 29 Sep 2009
• Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results. 29 Sep 2009
• Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension. 15 Sep 2009
• Discovery of orally active 3-pyridinyl-tropane as a potent nociceptin receptor agonist for the management of cough. 8 Sep 2009
• Short half-life hypnotics preserve physical fitness and altitude tolerance during military mountainous training. 30 Aug 2009
• Absolute bioavailability and pharmacokinetics of avosentan in man. 30 Aug 2009
• Dabigatran versus warfarin in patients with atrial fibrillation. 28 Aug 2009
• Can we rely on RE-LY? 28 Aug 2009
• Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents. 20 Aug 2009
• UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib. 10 Aug 2009
• Pharmacokinetics of concurrent administration of fosamprenavir and atazanavir without ritonavir in human immunodeficiency virus-negative subjects. 30 Jul 2009
• Catatonia recognition and treatment. 30 Jul 2009
• Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions. 30 Jul 2009
• Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors. 25 Jul 2009
• Surgical resection of renal cell carcinoma after targeted therapy. 15 Jul 2009
• Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib. 11 Jul 2009
• Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values. 7 Jul 2009

See a longer list of these articles.

Technical information about 'Pyridines'

Definition: Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.

Registry Number: 0

Descriptor UI: D011725

Alternative terms: Pyridines;

Related Mesh Headings: Piperidines;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D03.383.725;

Technical Notes: pyridine nucleotides will probably be NAD or NADP